Skip to main content
. 2021 Feb 10;13(4):721. doi: 10.3390/cancers13040721

Table 1.

Study description of the included studies.

Study (Author) Year Country Design Quality * Disease Patient (n = 2180) Primary Closure ** (n = 1206) Flap closure ** (n = 647) Mesh Closure ** (n = 327)
Ghouti et al. [21] 2005 France Retrospective cohort study 5 Anal cancer 41 15 26 -
Chessin et al. [6] 2005 USA Retrospective cohort study 5 Rectal cancer and anal cancer 78 59 19 -
Butler et al. [7] 2008 USA Retrospective cohort study 5 Rectal and anal cancer 111 76 35 -
Lefevre et al. [22] 2009 France Retrospective cohort study 7 Anal cancer 95 52 43 -
Chan et al. [23] 2010 UK Retrospective cohort study 4 Rectal cancer 51 21 30 -
Stelzner et al. [24] 2011 Germany Retrospective cohort study 3 Rectal cancer 74 46 28 -
Jacombs et al. [33] 2012 Australia Retrospective cohort study 5 Rectal cancer 203 164 39 -
Chokshi et al. [32] 2013 USA Retrospective cohort study 5 Rectal cancer, anal cancer, and other cancers 53 36 17 -
Davidge et al. [25] 2014 Canada Retrospective cohort study 4 Rectal cancer 177 125 52 -
O’Dowd et al. [27] 2014 Ireland Retrospective cohort study 8 Rectal cancer 39 27 12 -
Touny et al. [28] 2014 Egypt RCT 9 Rectal cancer 60 30 30 -
Althumairi et al. [26] 2015 USA Retrospective cohort study 4 Rectal cancer 67 56 11 -
Woodfield et al. [29] 2017 New Zeland Retrospective cohort study 3 Rectal cancer, anal cancer, and other cancers 68 37 31 -
Chaudhry et al. [30] 2018 USA Retrospective cohort study 5 Rectal cancer, anal cancer, and other cancers 562 288 274 -
Han et al. # [31] 2014 China RCT 9 Rectal cancer 102 19 - 83
Musters et al. # [10] 2017 Netherlands RCT 9 Rectal cancer 101 53 - 48
Habr-Gama et al. # [18] 2017 Brazil Retrospective cohort study 6 Rectal cancer 72 *** 48 - 22
Han et al. # [9] 2019 China Retrospective cohort study 6 Rectal cancer 228 54 - 174

* Newcastle–Ottawa quality assessment scale. ** Patient included in analysis. *** 2 patients had a flap closure. # Mesh type: Han et al. [9,31], Human acellular dermal matrix (Ruinuo, Qingyuanweiye Bio-Tissue Engineer- ing Ltd., Beijing, China); Musters et al. [10], Strattice ®® LifeCell non-crosslinked dermis porcine; Habr-Gama et al. [18], Bio-A®® WL Gore synthetic bioabsorbable.